Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I first-in-human dose escalation study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
    Journal Article

    Steensma, D. P.; Wermke, M.; Klimek, V. M.; Greenberg, P. L.; Font, P.; Komrokji, R. S.; Yang, J.; Brunner, A. M.; Carraway, H. E.; Ades, L.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines
    Research Letter

    Kozak, K. E.; Ouyang, L.; Derkach, A.; Sherman, A.; McCall, S. J.; Famulare, C.; Chervin, J.; Daley, R. J.; Morjaria, S.; Mauro, M. J.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • Hypomethylating agents and FLT3 inhibitors as maintenance treatment for acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation - A systematic review and meta-analysis
    Review

    Bewersdorf, J. P.; Allen, C.; Mirza, A. S.; Grimshaw, A. A.; Giri, S.; Podoltsev, N. A.; Gowda, L.; Cho, C.; Tallman, M. S.; Zeidan, A. M.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • In reply: Machine learning and artificial intelligence in neurosurgery: Status, prospects, and challenges
    Correspondence

    Dagi, T. F.; Barker, F. G. 2nd; Glass, J.
    Neurosurgery (2021)

    Fulltext@MSK | Save
  • CNS involvement in AML at diagnosis is rare and does not affect response or survival: Data from 11 ECOG-ACRIN trials
    Journal Article

    Ganzel, C.; Lee, J. W.; Fernandez, H. F.; Paietta, E. M.; Luger, S. M.; Lazarus, H. M.; Cripe, L. D.; Douer, D.; Wiernik, P. H.; Rowe, J. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Using PROMIS-preference (PROPr) scores to measure changes in quality of life after tyrosine kinase inhibitor discontinuation
    Meeting Abstract

    Winn, A.; Atallah, E.; Lin, L.; Thompson, J.; Moore, J.; Larson, R.; Cortes, J.; Mauro, M.; Pinilla, J.; Flynn, K.
    Quality of Life Research (2021)

    Fulltext@MSK | Save
  • Bridging chemotherapy prior to CD19-specific CAR T-cell therapy in children/young adults with relapsed/refractory acute lymphoblastic leukemia
    Meeting Abstract

    Shahid, S.; Ramaswamy, K.; Flynn, J.; Mauguen, A.; Boelens, J. J.; Forlenza, C.; Kernan, N.; Shukla, N.; Steinherz, P.; Sulis, M. L.; more...
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • OPTIC primary analysis: A dose-optimization study of 3 starting doses of ponatinib (PON)
    Meeting Abstract

    Cortes, J. E.; Apperley, J.; Lomaia, E.; Moiraghi, B.; Sutton, M. U.; Pavlovsky, C.; Chuah, C.; Sacha, T.; Lipton, J. H.; Schiffer, C.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Randomized, phase III study of early intervention with venetoclax and obinutuzumab versus delayed therapy with venetoclax and obinutuzumab in newly diagnosed asymptomatic high-risk patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): EVOLVE CLL/SLL study (SWOG S1925, NCT#04269902)
    Meeting Abstract

    Stephens, D. M.; Moseley, A.; Hill, B. T.; Pagel, J. M.; Shadman, M.; Fisch, M. J.; Danilov, A. V.; Ng, D.; Mato, A. R.; Brander, D. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Cardiac risk factors and adverse events among patients receiving first-line CLL treatment in a real-world community practice setting
    Meeting Abstract

    Mato, A. R.; Tang, B.; Azmi, S.; Yang, K.; Wallis, N.; Stern, J. C.; Hedrick, E.; Huang, J.; Sharman, J. P.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save